Anna Zhu

Anna Zhu

Auto-generated profile, based on publicly available information

Anna Zhu

German Diabetes Center (DDZ), Institute for Clinical Diabetology, Leibniz Center for Diabetes Research at Heinrich Heine Universität

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2022 in Journal of Internal Medicine
Verified
Journal Article
Open access
SSSha Sha
Sha Sha
TNThi Mai Ngoc Nguyen
Thi Mai Ngoc Nguyen
SKSabine Kuznia
Sabine Kuznia
TNTobias Niedermaier
Tobias Niedermaier
AZAnna Zhu
Anna Zhu
BSBen Schöttker
Ben Schöttker
Background: Meta‐analyses of randomized controlled trials (RCTs) have demonstrated the efficacy of vitamin D supplementation for reduced cancer mortality, all‐cause mortality, and respiratory tract infections. However, whether and to what extent this translates into effectiveness in real‐world practice is unknown.Methods: We assessed the association of vitamin D supplement use (as an over‐the‐counter drug or as part of a multivitamin product), vitamin D deficiency (25‐hydroxyvitamin D, 25[OH]D <30 nmol/L), and insufficiency (25[OH]D 30 to <50 nmol/L) with all‐cause and cause‐specific mortality in 445,601 participants, aged 40–73 years, from the UK Biobank cohort.Results: A total of 4.3% and a further 20.4% of the study participants reported regularly taking vitamin D or multivitamin supplements, respectively. Still, the majority had either vitamin D deficiency (21.0%) or insufficiency (34.3%). We detected 49 independent determinants of vitamin D deficiency and vitamin D supplement use and used them to adjust Cox regression models for all mortality outcomes. A total of 29,107 (6.5%) participants died during a median follow‐up time of 11.8 years. Both vitamin D deficiency and insufficiency were strongly associated with all mortality outcomes. Self‐reported vitamin D supplement use (83% over‐the‐counter/17% prescription drugs) and multivitamin intake were significantly associated with 10% and 5% lower all‐cause mortality, respectively. Furthermore, regular vitamin D supplement users had 11%, 11%, and 29% lower cancer, cardiovascular disease, and respiratory disease mortality than nonusers, respectively (not significant for cardiovascular disease mortality).Conclusion: This large study suggests that in the real world, the efficacy of vitamin D supplements in reducing mortality may be at least as good as observed in RCTs.

15 September 2022 in Environment International
Verified
Journal Article
Open access
HZHaofan Zhang
Haofan Zhang
AZAnna Zhu
Anna Zhu
LLLinxin Liu
Linxin Liu
YZYi Zeng
Yi Zeng
RLRiyang Liu
Riyang Liu
JJJohn S Ji
John S Ji
Vitamin D metabolism is essential in aging and can be affected by multiple environmental factors. However, most studies conducted single exposure analyses. We aim to assess the individual and combined effects of ultraviolet (UV) radiation, residential greenness, fine particulate matter (PM2.5), and ozone (O3) on vitamin D levels in a national cohort study of older adults in China. We used the 2012 and 2014 Chinese Longitudinal Healthy Longevity Survey data, and measured the environmental exposure in the same year. We interpolated the UV radiation from monitoring stations, measured residential greenness through satellite-derived Normalized Difference Vegetation Index (NDVI), modeled PM2.5 with satellite data, and estimated O3 using machine learning. We dichotomized serum 25-hydroxy vitamin D (25(OH)D), the primary circulating form of vitamin D, into non-deficiency (≥50 nmol/L) and deficiency (<50 nmol/L) categories. We used the generalized estimating equation for analysis, adjusted for sociodemographic information, lifestyle, physical condition, and season of blood draw, and calculated joint odds ratios based on the Cumulative Risk Index. We also explored the interaction between interested exposures, modification of participants' characteristics, and potential mediation. We included 1,336 participants, with a mean age of 83 at baseline. In single exposure models, the odds ratios of vitamin D deficiency (VDD) for per interquartile range increase in UV radiation, NDVI, PM2.5, and O3 and decrease were 0.39 (95 % CI:0.33,0.46), 0.90 (0.81,1.00), 1.65 (1.53,1.78), 1.67 (1.46,1.92), respectively. UV radiation mediated nearly 48 % and 78 % of the relationship between VDD and PM2.5 and O3, respectively. The association between UV radiation and VDD was stronger in females than men (OR: 2.25 vs 1.22). UV radiation, residential greenness can protect against VDD, while, PM2.5 and O3 increase the risk of VDD. UV radiation partly mediated the association between air pollution and VDD.

13 April 2022 in Journal of Internal Medicine
Verified
Journal Article
Open access
AZAnna Zhu
Anna Zhu
SKSabine Kuznia
Sabine Kuznia
TNTobias Niedermaier
Tobias Niedermaier
BHBernd Holleczek
Bernd Holleczek
BSBen Schöttker
Ben Schöttker
HBHermann Brenner
Hermann Brenner
Background: Epidemiological studies consistently find low concentrations of 25‐hydroxyvitamin D (25(OH)D) in blood to be associated with increased mortality, and a recent large‐scale Mendelian randomization study strongly supports a causal relationship among individuals with low vitamin D status. Evolving evidence suggested that bioavailable or free 25(OH)D may better predict mortality. We aimed to compare the prognostic values of vitamin D–binding protein (VDBP), total, bioavailable, complementary “nonbioavailable”, and free 25(OH)D for total and cause‐specific mortality in a large population‐based cohort study of older adults from Germany.Methods: Bioavailable, complementary “nonbioavailable”, and free 25(OH)D concentrations were calculated among 5899 participants aged 50–75 years, based on serum concentrations of total 25(OH)D, VDBP, and albumin. The cohort was followed with respect to total and cause‐specific mortality from recruitment in 2001–2002 up to the end of 2018. Multivariable Cox proportional hazards regression models were used to assess the associations between various vitamin D biomarkers and mortality, and further stratified by vitamin D status.Results: During a median follow‐up of 17.1 years, 1739 participants died, of whom 575, 584, and 94 died of cardiovascular diseases, cancer, and respiratory diseases, respectively. Very similar inverse associations with total mortality (hazard ratio (HR) per standard deviation decrease: 1.17, 95% confidence interval (CI): 1.11, 1.24 for total 25(OH)D; HR: 1.14, 95% CI: 1.08, 1.21 for bioavailable 25(OH)D; HR: 1.12, 95% CI: 1.06, 1.18 for free 25(OH)D) and cause‐specific mortalities were seen for all biomarkers of vitamin D status. The strongest associations were consistently seen for respiratory mortality. These inverse associations were strongest among participants with low vitamin D levels (<50 nmol/L). No significant associations were seen between VDBP and mortality.Conclusions: Total, nonbioavailable, bioavailable, and free 25(OH)D showed very similar inverse associations with total and cause‐specific mortality, which were strongest among those with low vitamin D status in this large population‐based cohort.

8 July 2025 in Diabetologia
Verified
Journal Article
Open access
PDF file
CHChristian Herder
Christian Herder
AZAnna Zhu
Anna Zhu
ASAndreas Schmitt
Andreas Schmitt
MSMaria C. Spagnuolo
Maria C. Spagnuolo
BKBernhard Kulzer
Bernhard Kulzer
NHNorbert Hermanns
Norbert Hermanns
Aims/hypothesis: People with diabetes and depression show large heterogeneity in their response to depression treatment. This study aimed to identify biomarkers of subclinical inflammation that were associated with improvement of depressive symptoms in people with type 1 diabetes and type 2 diabetes. Methods: The prospective analysis combined data from three studies (DIAMOS, ECCE HOMO and DDCT). A total of 332 people with type 1 diabetes and 189 people with type 2 diabetes completed both the baseline and 1 year follow-up examinations. Depressive symptoms were assessed using the Center for Epidemiological Studies depression scale (CES-D). Associations between baseline serum levels of 76 biomarkers of inflammation and 1 year changes in depressive symptoms were estimated using multiple linear regression. Results: In people with type 2 diabetes, higher levels of 26 biomarkers were associated with greater reductions in depressive symptoms (β=0.128 to 0.255; p<0.05), whereas in people with type 1 diabetes, higher levels of 13 biomarkers were linked with lower reductions in depressive symptoms (β=−0.189 to −0.094; p<0.05). A significant effect modification was observed for 33 biomarkers (p interaction<0.05). The positive associations in type 2 diabetes were strongest for improvements in cognitive-affective and anhedonia symptoms, while the inverse associations in type 1 diabetes were strongest for improvements in somatic symptoms. Conclusions/interpretation: Higher baseline levels of multiple biomarkers of inflammation were associated with greater depression reduction in type 2 diabetes but lower depression reduction in type 1 diabetes. There were also diabetes type-specific differences in the associations with symptom clusters of depression. This suggests that different inflammation-related pathways may be relevant for the response to depression treatment in people with type 1 diabetes or type 2 diabetes. Graphical


3 February 2026 in Journal of the American Heart Association
Verified
Journal Article
Open access
HMHaifa Maalmi
Haifa Maalmi
KWKristiaan Wouters
Kristiaan Wouters
NSNicolaas Schaper
Nicolaas Schaper
AZAnna Zhu
Anna Zhu
JHJordi Heijman
Jordi Heijman
CSCoen D. A. Stehouwer
Coen D. A. Stehouwer
Background: Inflammatory biomarkers, including immune cells appear associated with reduced heart rate variability (HRV), an indicator of cardiac autonomic nervous dysfunction. However, the influence of leukocytes on HRV and their relation across sex and glucose metabolism status remains unclear. Hence, we sought to investigate the cross‐sectional association between leukocytes and HRV indices and their association across sex and glucose metabolism status in a general population. Methods: We retrieved cross‐sectional data of 1888 participants of the Maastricht Study who completed the baseline survey between November 2010 and December 2017. Blood leukocyte numbers (including neutrophils, monocytes, basophils, eosinophils, and lymphocytes) were determined with an automated hematology analyzer. Qualitative changes within lymphocytes were assessed with flow cytometry. HRV indices were assessed using a 24‐hour ECG. Time‐domain and frequency‐domain HRV index average scores were calculated. We regressed HRV average scores on standardized leukocytes and adjusted the models for several covariates. Results: In fully adjusted models, higher neutrophil (−0.07 [−0.11 to −0.03]; false discovery rate (FDR)‐corrected P value, P FDR =0.006) and monocyte (−0.05 [−0.09 to −0.02]; P FDR =0.020) counts were associated with a lower time‐domain average score. Higher neutrophil (−0.07 [−0.11 to −0.03]; P FDR =0.006) and monocyte (−0.05 [−0.09 to −0.01]; P FDR =0.020) counts were also associated with a lower frequency‐domain HRV index average score. No effect modification by either sex or glucose metabolism status was found ( P intFDR >0.05). There were no other associations between immune cells and HRV indices. Conclusions: Higher neutrophil and monocyte counts were associated with lower HRV, irrespective of sex and glucose metabolism status. This suggests a role of these cells reflecting innate immune processes and inflammatory response in cardiac autonomic nervous dysfunction.